Directory Image
This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Privacy Policy.

Global obesity surgery devices market size and market share by players (2022-2030)

Author: Kalyani Badkas
by Kalyani Badkas
Posted: Oct 11, 2022

Persistence Market Research Released New Market Report on "Global Market Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020" the global obesity surgery devices market was valued at USD 1,432.4 million in 2014 and is expected to grow at a CAGR of 9.6% from 2014 to 2020, to reach an estimated value of USD 2,489.5 million in 2020.

Globally, the obesity surgery devices market is witnessing significant growth due to increasing obesity epidemic and increasing sedentary lifestyle and junk food habits. Increasing prevalence of obesity among children and adults is posing a threat in both developed and developing nations. Excess body weight directly contributes to increasing risk of stroke, heart diseases, type-2 diabetes and some forms of cancer.

Get Free Sample Copy of this Report@! https://www.persistencemarketresearch.com/samples/2894

Some of the major players in the obesity surgery devices market:

  • Johnson & Johnson.
  • Medtronic, Inc.
  • Apollo Endosurgery Inc.
  • Aspire Bariatrics.
  • Spatz FGIA Inc.
  • MetaCure.
  • IntraPace Inc

Obesity surgery is a broadly available treatment for persons with severe and complex obesity. However, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable. In addition, selective nature of obesity surgery, due to its complications, restricts growth of obesity surgery devices market. The global obesity surgery device market is estimated at USD 1,432.4 million in 2014. It is likely to grow at a CAGR of 9.6% from 2014 to 2020 to reach USD 2,489.5 million in 2020.

North America is facing serious public health problems due to obesity. The U.S. accounted for 13% of obese persons worldwide in 2013. Similarly, according to the Centers for Disease Control and Prevention (CDC), 24.5% of Americans were suffering from obesity in 2004 and this increased to 35.7% in 2011. In 2011, Roux-en-Y gastric bypass was the most common procedure in North America.

In Europe, obesity is a major public health challenge in Europe. According to the Organization for Economic Co-operation and Development (OECD) in 2010, approximately 52% of the population in the European Union was obese or overweight.

However, in Asia obesity has reached epidemic proportions in many countries in Asia Pacific. South East Asia and Western Pacific regions are facing an epidemic of obesity-associated diseases such as cardiovascular disorders and diabetes. China and India accounted for around 15% of the world’s obese population worldwide in 2013.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/2894

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the "missing" link between "customer relationships" and "business outcomes’. The best possible returns are assured therein.

Contact us:

Persistence Market Research

Address – 305 Broadway, 7th FloorNew York City,

NY 10007 United States

U.S. Ph. – +1-646-568-7751

USA-Canada Toll-free – +1 800-961-0353

Sales – sales@persistencemarketresearch.com

Website – https://www.persistencemarketresearch.com

About the Author

Transparency Market Research is here to provide companies a one-stop solution with regards to bettering customer experience.

Rate this Article
Leave a Comment
Author Thumbnail
I Agree:
Comment 
Pictures
Author: Kalyani Badkas
Professional Member

Kalyani Badkas

Member since: Oct 11, 2022
Published articles: 1014

Related Articles